Binge Eating Disorder

• FDA label_change · 2026-04-23
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Vyvanse to update its labeling (indications/usage) following regulatory action.

• FDA label_change · 2024-01-17
  FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for lisdexamfetamine dimesylate from Hikma Pharmaceuticals USA Inc., resulting in changes to the pro…

• FDA label_change · 2013-06-14
  FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Vyvanse to update the product labeling.